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Abstract
The self-management behaviors of individuals with medical conditions that have an unknown 
etiology have not been studied. This study assesses the relationship between illness perceptions 
and various illness self-management behaviors in patients undergoing clinical genomic sequencing 
to identify a genetic cause for their condition. Hierarchical linear regression, Poisson linear 
regression, and logistic regression were used to assess the effect of illness perceptions (i.e., 
perceived consequences, timeline, personal control, treatment control, identity, concern, 
understanding, emotional impact, and causal beliefs as measured by the Brief Illness Perceptions 
Questionnaire) on healthcare use, prescription medication use, and doctor recommended 
supplement use, respectively (n = 200). Analyses revealed that (1) illness identity beliefs were 
positively associated with healthcare use (β =.20, p =.04), (2) both treatment control beliefs (B =.
03, p =.02) and genetic causal beliefs (B =.17, p =.049) were positively associated with 
prescription medication use, and (3) both timeline beliefs (OR =1.23, p =.02) and emotional 
impact (OR =1.20, p =.02) were positively associated with doctor recommended supplement use. 
These findings can be used to inform the development of guidelines for treating patients who are 
seeking a genetic diagnosis for their illness.
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In the context of chronic diseases, self-management broadly refers to strategies patients use 
to manage the actual or potential impact of their disease (Richard & Shea, 2011). It is 
characterized as a “cluster of daily behaviors” to manage health (Glasgow & Anderson, 
1999, p. 2090). The self-management behaviors of individuals with well-defined medical 
conditions (e.g., diabetes) have been studied extensively. Furthermore, a patient’s lifestyle 
behaviors (e.g., diet, exercise) and adherence to treatments (e.g., medications and other 
therapies) are a common target of self-management interventions (e.g., Lorig et al., 2001). 
Patients may also consult with healthcare professionals about potential treatments or 
strategies for managing their symptoms (Richard & Shea, 2011), although these self-
management behaviors are less frequently studied.
In contrast, the self-management behaviors of individuals with unexplained medical 
conditions are harder to characterize. These individuals often face misdiagnosis, diagnostic 
delay, and uncertainty in treatment options (Nettleton et al., 2005; The Lancet, 2009; van der 
Kloot et al., 2010). Research reveals that these factors contribute to extensive testing and 
consultations with specialists. Other work shows that individuals engage in these behaviors
— seeking an explanation or diagnosis —in order to more clearly understand what to expect 
for the future and how to manage a health concern (Koopman & Schweitzer, 1999; Lewis, 
Skirton, & Jones, 2010). Although individuals’ beliefs about their illness (such as those 
concerning the severity of the illness and its impact on daily life) have been found to 
contribute to self-management behaviors across a variety of populations (Bratzke et al., 
2015), individuals who cannot identify an explanation, diagnosis, or appropriate treatment 
options for their condition are likely to experience increased levels of frustration and 
uncertainty as a result (Nettleton et al., 2005), and we hypothesize that they may also rely 
more heavily on their beliefs about their illness because they lack the information they need 
for self-management.
Accordingly, the present study informs prior research on self-management by investigating 
the association between illness beliefs and self-management behaviors in a population of 
patients who are undergoing whole exome sequencing (WES) to identify a potential genetic 
explanation for their condition. Unlike individuals with medically unexplained symptoms 
(MUS) who have symptoms with no known physical cause (Gormley, 2014), and therefore 
are dismissed by medical professionals or made to feel like it is “all in the mind” (Nettleton 
et al., 2005), this population experiences symptoms that are suspected to be genetic in 
nature, but has yet to receive a definitive genetic explanation for them. This uncertainty 
about what caused their condition can shape the beliefs patients bring with them into the 
clinical encounter and influence the self-management behaviors they utilize as they seek a 
genetic diagnosis. Just as a clinical diagnosis provides valuable information to those with 
MUS, a genetic explanation may help clarify the potential of recurrent risk, implications for 
family planning, and inform illness management decisions of people who are affected by a 
disease process that strongly appears to be genetic in origin, although that genetic cause has 
not yet been identified.
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Illness Beliefs
Leventhal’s common-sense model (CSM) of self-regulation (1984, 2003) provides a 
theoretical framework for understanding how individuals’ beliefs about their illness 
(referred to as illness perceptions) can influence their self-management behaviors. This 
theoretical framework states that upon experiencing a health threat, individuals engage in an 
iterative coping process based on the cognitive and emotional representations of that threat. 
The effectiveness of this coping process is evaluated, and the cognitive and emotional 
representations of the health threat are re-appraised based on the evaluation of this coping 
behavior. The CSM identifies five core domains of illness perceptions individuals hold 
about a health threat: identity, cause, consequences, timeline, and control (Leventhal et al., 
2003). Identity refers to how individuals define their health threat and the symptoms 
associated with that health threat. Cause refers to the factors individuals believe led to the 
health threat. Consequences are the expected outcomes and perceived impact of the health 
threat. Timeline is the duration of the health threat, and is usually conceptualized as being of 
limited duration (acute) or as persisting for a longer and possibly indefinite amount of time 
(chronic). Finally, Control refers to individuals’ beliefs about the extent to which personal or 
medical actions can help control the health threat. These cognitive representations work in 
parallel with emotional representations to direct coping behaviors (Leventhal et al., 1984).
Self-management behaviors have been identified as one manifestation of coping responses 
to health threats (Leventhal et al., 2003), and the framework of illness perceptions provided 
by the CSM has been used to predict illness self-management behaviors for a variety of 
populations with well-defined medical conditions, including asthma, chronic obstructive 
pulmonary disease, and cardiovascular disease (French et al., 2006; Hagger & Orbell, 2003; 
Kaptein et al., 2008; Petrie et al., 2007). For instance, a meta-analytic review (Hagger & 
Orbell, 2003) found that perceived controllability is significantly associated with active 
coping behaviors, such as adherence to diet and drug regimens. Previous literature assessing 
behavioral outcomes in patient populations has found that timeline beliefs and emotional 
impact were associated with medication adherence in end-stage renal disease patients 
(O’Connor et al., 2008); greater perceived consequences predicted healthcare use among 
adults with congenital heart disease (Schoormans et al., 2014); identity beliefs, control 
beliefs, perceived consequences, and understanding predicted attendance at cardiac 
rehabilitation following an acute myocardial infarction (French et al., 2006); and timeline 
beliefs, identity beliefs, and causal beliefs were associated with medication adherence 
among asthma patients (Kaptein et al., 2008). Other research has found positive associations 
between illness identity, emotional impact, and perceived consequences with healthcare 
utilization (Frostholm et al., 2005; Jackson et al., 2006). As noted, however, the illness 
perceptions framework is generally utilized in populations with conditions that have clear 
treatment options, implications for family, and prognoses. Little is known about how 
individuals with medical conditions with uncertain etiology perceive their illness and its 
impact on their attempt to manage their conditions in spite of this uncertainty. Therefore, 
applying the CSM illness perceptions framework to individuals undergoing diagnostic 
genomic sequencing can help us understand how illness perceptions are associated with 
illness self-management in this population.
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Current Study
The current study assesses the association between illness perceptions and various self-
management behaviors (health care use, prescription medication use, and supplement use) 
among individuals who are seeking a genetic explanation for their presenting health 
condition. In the context of symptomatic, chronic disease management, these three self-
management behaviors – health care use, prescription medication use, and supplement use – 
indicate people’s attempts to manage their health and therefore serve as useful targets for 
analysis to understand illness self-management decisions.
Participants were adult patients who were having diagnostic WES as part of a study 
evaluating use of genomic sequencing in clinical care. These participants have all received a 
clinical diagnosis and are currently seeking a genetic explanation for their medical 
condition, which can provide valuable information regarding the potential for recurring risk 
and implications for family planning. In light of the iterative nature of illness perceptions 
and coping processes (Petrie & Weinman, 2012), understanding the illness perceptions 
people hold before receiving results from a genetic test, as well as the concurrent links 
between these illness perceptions and illness self-management, can provide valuable insight 
into how pre-existing illness perceptions may contribute to behavioral responses to 
subsequent results from these tests (Lerman et al., 2002).
This cross-sectional study assesses the relationship between illness perceptions, healthcare 
use, prescription medication use, and doctor recommended supplement use before receiving 
genomic sequencing results. Among this population of symptomatic individuals who are 
seeking a genetic etiology for their condition, we expected that some illness perceptions may 
be more strongly associated with these self-management behaviors than what has been 
reported in the literature on other populations. Specifically, we hypothesized that illness 
identity, beliefs about treatment control, and emotional impact would be independently, 
positively associated with both healthcare use and prescription medication use. Research on 
supplement use in healthy populations suggests that supplements are viewed as a health 
management strategy that is distinct from other “medical” strategies, such as medication use, 
and one that allows individuals to exert some degree of personal control over their health 
(Nichter & Thompson, 2006). Consequently, we hypothesized that only beliefs about 
personal control would be independently, positively associated with supplement use. We 
hypothesized that no other illness perceptions (i.e. consequences, timeline, concern, and 
cause) would be associated with any of the outcomes.
Methods
Participants
Participants were adult patients (n = 223) participating in the North Carolina Clinical 
Genomic Evaluation by NextGen Exome Sequencing (NCGENES) study at the University 
of North Carolina at Chapel Hill (UNC). NCGENES investigates the clinical use of 
diagnostic genomic sequencing in patient populations affected by a health concern that 
appears to have a genetic cause, although that cause has not yet been identified. Their health 
concerns were related to potentially heritable cancers, cardiogenetic conditions, 
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neurodevelopmental disorders, congenital malformations, retinal disease, and other 
conditions such as hemophilia and mitochondrial disorders. The study used whole exome 
sequencing (WES), a form of next generation genomic sequencing (Lohmann & Klein, 
2014), to identify explanatory genetic variants. Children were also sequenced in the study 
and their parents participated in study assessments, but their data were not included in 
current analyses. Adult patient participants were recruited from the UNC Cancer and Adult 
Genetics Clinic and Vidant Medical Center (Greenville, NC) by referral from a physician 
identifying them as having a condition that is highly suspected to have a genetic cause. 
Participants were excluded if they did not speak English or Spanish or if they had already 
received a genetic diagnosis through prior testing. Of the eligible participants contacted for 
the study (n = 724), 347 agreed to receive WES (46.9%) and completed the baseline 
assessment between September 2012 and July 2014. Parent respondents were excluded from 
the analysis, so the current study is based on data from the subset of 223 adult patients who 
have completed the first telephone survey as of July 2014.
Procedures
All participants completed an intake questionnaire mailed to their home prior to meeting 
with a genetic counselor to enroll in the study. At the enrollment meeting, participants met 
with the genetic counselor, learned about WES, completed informed consent procedures, 
and provided a blood sample; no personalized genetic counseling was provided at this time. 
Two weeks later, participants completed a structured telephone interview conducted by 
trained research assistants (Time 1 interview) followed by a mailed questionnaire (Time 1 
questionnaire). The intake questionnaire, Time 1 telephone interview, and Time 1 
questionnaire were all completed before receiving WES results and are considered baseline 
data. Data collected at subsequent follow-up assessments (i.e., two weeks after return of 
diagnostic WES results and three months and six months after that) were not used in the 
present study, which was focused on understanding illness perceptions people hold before 
receiving results from a genetic test and their concurrent associations with illness self-
management. Demographic information was obtained from the intake questionnaire and data 
on illness perceptions, healthcare utilization, prescription medication use, and supplement 
use was collected during the Time 1 telephone interview. All procedures were approved by 
the Institutional Review Boards of the University of North Carolina at Chapel Hill and 
Vidant Medical System.
Measures
Illness perceptions were assessed with the Brief Illness Perceptions Questionnaire (IPQ) 
(Broadbent et al., 2006). This 9-item self-report scale measures cognitive and emotional 
illness perceptions. Each item corresponds to one illness perceptions domain including (1) 
consequences, (2) timeline, (3) personal control, (4) treatment control, (5) identity, (6) 
concern, (7) understanding, (8) emotional impact, and (9) causal beliefs. Responses for 
items 1–8 are scored on a scale from 0 to 10. Higher values indicate more negative beliefs 
for items 1, 2, 5, 6, and 8. Higher values indicate more positive beliefs for items 3, 4, and 7.
Item 9 is one open-ended question assessing causal beliefs by asking participants to “List in 
rank-order the three most important factors that you now believe caused your health 
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concern.” Two variables were extracted from responses to this question. First, we identified 
participants who most strongly endorsed a genetic causal model for their illness by 
dichotomizing responses to indicate those who listed a genetic or hereditary cause as the 
most important factor (1) and those who did not (0). Second, we identified participants who 
were most uncertain about the cause of their condition (indicated by the fact that they did 
not have a genetic nor non-genetic explanation) by dichotomizing responses to indicate 
those who responded “don’t know” and provided no further answers to the causal beliefs 
question (1) and those who provided at least one answer (0). These two dichotomous 
variables were used to measure causal beliefs.
Healthcare utilization was measured with one question from the National Health and 
Nutrition Examination Survey (NHANES) asking “During the past 12 months, how many 
times have you seen a doctor or other health care professional about your health at a doctor’s 
office, a clinic, hospital emergency room, at home or some other place? Do not include 
times you were hospitalized overnight” (Center for Disease Control and Prevention, 2013). 
Response options were: “None,” “1,” “2 to 3”, “4 to 9,” “10 to 12,” and “13 or more” and 
responses were analyzed as a continuous variable.
Prescription medication use and supplement use were measured with two questions created 
for the NCGENES study: (1) “How many medications prescribed by a doctor do you take 
each day or on most days?” and (2) “How many vitamins, minerals, herbs, or other 
supplements recommended by a doctor do you take each day or on most days?” Participants’ 
responses for prescription medication use were analyzed as a continuous variable. Their 
responses for doctor recommended supplement use were positively skewed and kurtotic 
(mean=1.57, SD=1.91, range=0–13, skew=2.31, kurtosis=8.24); therefore this variable was 
dichotomized to indicate those who took one or more supplements (1) and those who took 
no supplements (0).
Covariates. Research has linked age, gender, certain medical conditions, and disease 
severity to healthcare utilization, medication use, and supplement use (Satia-Abouta et al., 
2003; Schoormans et al., 2014), therefore all analyses controlled for age, gender, diagnostic 
category, and physical functioning, as well as education and income. Covariates measured at 
enrollment include age at enrollment (continuous), gender (female=1), income (continuous), 
and education (more than 4 year college=1), physical functioning, and diagnostic category. 
Physical functioning was measured through the Karnofsky Performance Status scale, scored 
on a scale of 1 to 8 and coded so that higher scores reflect better physical functioning 
(Karnofsky et al., 1948). This variable accounts for differences in symptoms and physical 
functioning present in our population that may confound the relationship between illness 
beliefs and self-management. Diagnostic category is a label assigned to each participant 
corresponding to his or her clinical diagnosis (e.g., cancer, cardiogenetics, 
neurodevelopmental disorders, congenital malformations), which also informs the panel of 
genetic variants to be examined during WES. This variable was used to control for 
differences in healthcare and self-management experiences inherent to the condition. 
Indicator codes with cancer as the reference group (0) were used because this was the largest 
and most homogenous group in terms of pre-existing healthcare needs.
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Sample
Based on z-scores >|3.3| (Tabachnick & Fidell, 2001), nine outliers (six for Timeline and 
three for prescription medication use) were detected. Analyses were conducted with and 
without the outliers, and all nine cases were removed from the sample because they were 
found to have a biasing effect on the results. Fourteen cases did not provide relevant answers 
to the causal beliefs question and were removed from analyses. As a result, the final sample 
size for all analyses was 200.
Analysis plan
Descriptive statistics of IPQ scores were used to evaluate illness perceptions in this sample. 
Hierarchical multivariate linear regression was used to evaluate the association between IPQ 
items and healthcare utilization. Poisson linear regression was used to evaluate the 
association between IPQ items and prescription medication use in order to account for the 
use of count data. Hierarchical logistic regression was used to evaluate association between 
IPQ predictors and doctor recommended supplement use. All analyses were conducted using 
SPSS 22.0 (IBM Corp. Released 2013. Armonk, NY).
Results
Descriptive statistics on sample demographics can be found in Table 1. The mean age for 
the sample was 46 years old. Seventy-one percent of the sample was female, 80% were non-
Hispanic white, 59% had an annual household income of $60,000 or more, and 46% had a 4-
year college education or more. Most of the sample has a medical condition classified as 
“other” (38%), followed by cancer (36%), neurodevelopmental disorders (14%), 
cardiogenetic disorders (11%), and congenital malformations (1%). The “other” category 
was used for conditions that did not appear frequently in the sample and included conditions 
such as retinal disease, hearing loss, hemophilia, or mitochondrial disorders. More than half 
the sample (53%) had fewer than 10 healthcare visits in the previous 12 months. The mean 
number of prescription medications taken was 3.7, and 66% of the sample reported taking 
supplements recommended by a doctor. Overall, participants exhibited moderate illness 
perceptions scores (means ranged from 4.2–7.9), except for timeline beliefs (mean=9.0, 
SD=1.88). More than half the sample endorsed a strong genetic causal model for their illness 
(52.0%), and 13% were most uncertain about the cause of their illness, indicating they 
“don’t know” what caused their illness and provided no further responses. Bivariate 
correlations of illness perceptions and outcome variables can be found in Table 2.
Healthcare utilization
Table 3 presents the results of the multivariate linear regression of IPQ variables on 
healthcare utilization in the previous 12 months. Adding the IPQ variables did not 
significantly improve the variance explained by the model (R2 change=.07, F(10, 180)=1.69, 
p=.09). In the final model, being female (β=.30, t(198)=4.26, p<.001) significantly predicted 
healthcare use. Relative to participants with cancer, having a neurodevelopmental disorder 
(β=−.22, t(198)=−2.62, p=.009), a congenital disorder (β=−.14, t(198)=−2.02, p=.045), or 
having a disorder categorized as “other” (β=−.13, t(198)= −2.19, p=.03) was associated with 
significantly fewer healthcare visits. As expected, stronger identity beliefs, indicating greater 
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symptom severity, were associated with greater healthcare utilization (β=.20, t(198)=2.04, 
p=.04).
Prescription medication use
Table 4 presents the results of the Poisson regression model of IPQ variables on prescription 
medication use. Adding the IPQ variables significantly improved the model fit compared to 
the reduced model with only the covariates (X2(10)=19.79, p=.03). In the final model, age 
was positively associated with prescription medication use (B=0.01, Wald X2(1)=20.31, p<.
001), as was being female (B=.41, Wald X2(1)=19.00, p<.001). Relative to participants with 
cancer, having a cardiogenetic condition (B=.83, Wald X2(1)=44.76, p<.001) or a condition 
classified as “other” (B=.40, Wald X2(1)=13.25, p<.001) was associated with greater 
prescription medication use. Better physical functioning was negatively associated with 
prescription medication use (B=−.02, Wald X2(1)=30.05, p<.001). As expected, stronger 
treatment control beliefs were associated with greater prescription medication use (B=.034, 
Wald X2(1)=5.69, p=.02). Furthermore, those who most strongly endorsed a genetic cause 
for their health concern had higher prescription medication use than those who did not most 
strongly endorse a genetic cause for their health concern (B=.17, Wald X2(1)=3.88, p=.049).
Doctor recommended supplement use
Table 5 presents the results of the logistic regression of IPQ variables on supplement use. 
Adding the IPQ variables significantly improved the model fit compared to the reduced 
model with only the covariates (X2(10)=20.64, p=.024). No covariates were significantly 
associated with doctor recommended supplement use after controlling for all other variables 
in the model. Unexpectedly, those with higher timeline scores, indicating they believed their 
health concern would last a long time, had 1.23 times the odds of using supplements 
recommended by a doctor than those with lower timeline scores (95% CI=[1.03, 1.46]; p=.
02). Additionally, those who reported that their health condition caused a higher emotional 
impact had 1.20 times the odds of using supplements recommended by a doctor than those 
who reported a lower emotional impact (95% CI=[1.03, 1.40]; p=.02).
Discussion
This study extended research on illness perceptions—previously focused on patient 
populations with relatively well-defined conditions —to an adult patient population 
undergoing genomic sequencing to find a genetic cause for their medical condition. We 
hypothesized that illness identity, beliefs about treatment control, and emotional impact 
would be positively associated with healthcare use and prescription medication use, and that 
only beliefs about personal control would be positively associated with supplement use.
Unlike prior research, our findings indicated a relatively weak role for illness perceptions 
compared to demographic and medical variables in these self-management behaviors. In 
each analysis, only one or two IPQ variables were significantly associated with the outcome 
of interest after controlling for all other covariates, and these associations differed across 
outcomes. Although only illness identity beliefs were positively associated with healthcare 
utilization, both treatment control beliefs and genetic causal beliefs were positively 
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associated with prescription medication use, and both timeline beliefs and emotional impact 
were positively associated with doctor recommended supplement use. This suggests that 
illness perceptions may offer some insight into various self-management behaviors in this 
population (people with unexplained medical conditions seeking a genetic explanation 
through WES) beyond that of demographic and medical factors, but their influence is unique 
to the type of health behavior in question.
In accordance with the chronic nature of their conditions, the mean timeline score in our 
sample indicated that most individuals believed their condition would last a long time. In 
addition, more than half the sample endorsed genetic causal beliefs, and an eighth of the 
sample expressed they “don’t know” what caused their health concern. This speaks to the 
unique circumstances of the patients in our study, all of whom were seeking to confirm a 
potential genetic cause for their health concern.
Consistent with literature on illness perceptions (Leventhal et al., 1984), symptom appraisal 
(i.e., identity) was the most salient illness belief linked with healthcare utilization, 
suggesting that symptom appraisal is important for deciding how to manage a health 
concern, specifically whether or not to consult a professional. However, contrary to the 
theory and other literature on healthcare utilization (Frostholm et al., 2005), emotional 
impact was not significantly associated with healthcare use in this sample. Similarly, 
perceived consequences were not significantly associated with healthcare use, despite 
significant bivariate correlations with healthcare use. This finding may partly be attributed to 
high correlations among perceived consequences, identity beliefs, concern, and emotional 
impact in this sample; whereas, in theory, each item represents an independent illness 
perceptions domain, these results suggest that perceived consequences, concern, and 
emotional impact may influence healthcare use through similar mechanisms.
This study also found that beliefs about treatment control and genetic causal beliefs were 
significantly associated with prescription medication use. This finding is consistent with 
other evidence regarding the joint effects of illness perceptions and treatment beliefs on 
behavior, which has suggested that beliefs about treatment, not just illness, are important 
contributors to health self-management behaviors (French et al., 2013; Rajpura & Nayak, 
2014). Similar to the previous discussion, these findings also suggest that perceived 
consequences, identity beliefs, and emotional impact may influence prescription medication 
use through similar mechanisms, or they can be accounted for through other demographic or 
medical variables in this sample, and therefore were not independent predictors of 
prescription medication use.
Our finding linking endorsing a genetic causal model for a health concern with greater 
prescription medication use supports the importance of considering etiological models of 
disease when examining self-management behavior. Marteau and Weinman (2006) argue 
that the strategies that individuals employ to cope with a health concern will in part depend 
on what the individuals believe caused the health threat. These researchers apply this 
framework to theorize about behavioral responses to DNA risk information, claiming that 
individuals who believe their condition is genetic do not adhere to lifestyle 
recommendations because they believe that the genetic nature of the disease makes it 
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uncontrollable and/or only responsive to biological treatment. The positive association 
between genetic causal beliefs and prescription medication use is a compelling contribution 
to Marteau and Weinman’s argument.
No known research has applied a validated measure of illness perceptions to examine the 
relation between illness perceptions, as identified by the CSM, and supplement use a patient 
population such as ours; therefore, this study extends the illness perceptions literature to 
include a distinct self-management behavior patient populations may use to manage their 
health. Furthermore, doctor recommended supplement use represents a unique type of self-
management behavior because, although it is a helpful health management recommendation, 
it may not carry the same medical connotation that healthcare use and prescription 
medication use does (Nichter & Thompson, 2006). In this analysis, the results revealed that 
timeline beliefs and emotional impact were significantly associated with doctor 
recommended supplement use. When individuals believe their health concern will last for a 
long time, they may be more willing to explore unconventional or alternative therapies to 
manage their health, such as supplement use. These findings also highlight effects of 
emotional impact on the likelihood of taking doctor recommended supplements. This 
association is consistent with the theoretical and empirical literature on illness perceptions, 
as well as other research examining the role that emotions play in decision-making (Slovic 
et al., 2005). Notably, timeline beliefs and emotional impact were also the only two 
variables significantly associated with supplement use in bivariate correlations, suggesting 
that the effect of these variables on doctor recommended supplement use cannot be 
accounted for by other demographic or medical variables. This observation further supports 
the notion that supplements represent a type of self-management behavior that is uniquely 
driven by particular beliefs about illness.
In sum, this study found that five different illness perceptions variables were uniquely 
associated with healthcare use, prescription medication use, and doctor recommended 
supplement use among symptomatic adults undergoing diagnostic genomic sequencing, and 
different illness perceptions predicted each outcome. The primary limitation in this study is 
its cross-sectional nature, which precludes us from drawing causal inferences on the 
relationship between these illness perceptions and the target outcomes. The reciprocal nature 
of illness perceptions and behavior also makes it challenging to determine the directionality 
of influence. Furthermore, the low response rate of eligible participants limits the 
generalizability of these findings to other similar populations. We also know little about 
participants’ history of seeking information about their presenting health condition, 
including how long they had been seeking an explanation for its cause. Because their 
medical history may provide an important context for their current illness perceptions, future 
research should include key features of patients’ medical history.
Another limitation relates to the measurement of our key variables. The Brief Illness 
Perceptions Questionnaire uses only one or two items to measure each domain identified by 
the CSM. Although this brief measure has been validated in other studies, one item may not 
be sufficient to assess complex phenomena such as illness perceptions. Our study used the 
shortened version of the measure in consideration of participant burden when completing the 
surveys, but future research should consider using the full measure to more thoroughly 
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assess illness perceptions. Furthermore, although we contend that healthcare use, 
prescription medication use, and supplement use broadly represent actions taken by 
individuals to manage their health, our measures did not distinguish the reasons why 
individuals sought health care services or took medication or supplements, limiting our 
inferences about self-management behavior in this sample.
Nonetheless, this study provides useful insight into the self-management behaviors of 
individuals with medical conditions for which there is no clear etiology. Understanding how 
illness perceptions contribute to self-management behaviors among these individuals can 
help guide patient-provider interactions surrounding diagnostic testing and direct health 
decision-making. This information may also be used to guide the development of guidelines 
for treating patients with illness that have a suspected, but unclear, cause. This study 
provides information that can be followed up by further research to build a knowledge base 
needed to help improve health outcomes of individuals facing medical conditions with 
uncertain etiology.
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Table 1
Participant characteristics, July 2012 to July 2014 (n=200)
%(n) M(SD) Observed Range
Age 46 (14.7) 18 – 78
Female 70.5 (141)
Non-Hispanic White 79.5 (159)
Annual income $60,000 or more 59.0 (118)
Four year college education or more 45.5 (91)
Diagnostic category
 Cancer 36.0 (72)
 Cardiogenetics 11.0 (22)
 Neurodevelopmental disorders 14.0 (28)
 Congenital malformations 1.0 (2)
 Other 38.0 (76)
Healthcare visits
 0 0.5 (1)
 1 1.5 (3)
 2 to 3 16.0 (32)
 4 to 9 35.0 (70)
 10 to 12 13.5 (27)
 13 or more 33.5 (67)
Prescription medication use 3.7 (3.3) 0 – 14
Use doctor recommended supplements 66.0 (132)
Illness perceptions
 Consequences 6.4 (2.98) 0 – 10
 Timeline 9.0 (1.88) 2 – 10
 Personal control 4.2 (3.05) 0 – 10
 Treatment control 6.2 (3.15) 0 – 10
 Identity 5.6 (3.10) 0 – 10
 Concern 7.4 (2.87) 0 – 10
 Understanding 7.9 (2.47) 0 – 10
 Emotional impact 5.2 (3.04) 0 – 10
 Cause: genetic 52.0 (104)
 Cause: unknown 12.5 (25)
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Table 5
Logistic regression of supplement use on illness perceptions (n=200)
Independent variable OR 95% CI p
Consequences 0.89 0.76 1.05 0.173
Timeline 1.23 1.03 1.46 0.021
Personal Control 1.11 0.98 1.25 0.115
Treatment Control 0.99 0.87 1.11 0.811
Identity 0.91 0.77 1.07 0.236
Concern 1.08 0.92 1.27 0.341
Understanding 1.07 0.93 1.24 0.341
Emotional impact 1.20 1.03 1.40 0.019
Cause: genetic 0.50 0.24 1.06 0.490
Cause: unknown 0.67 0.22 2.06 0.672
Note: Model X2(19)=31.42, p=0.04; Nagelkerke R2=0.201
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